Wednesday 14 October 2026
Export MOH’s income statement to Excel — free account
Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue fell 4.84%, EPS fell 75.0%, free cash flow grew 5.81% and total debt rose 10.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
209.87
5.51
+2.70%
Follow MOH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
19.71% | 11.02% | 4.48% | (0.16%) | |
Piotroski F-Score |
4 | 4 | 6 | 4 | |
| 5.61% | 3.03% | 1.15% | (0.04%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
16.37% | 8.78% | 3.46% | (0.13%) | |
Average Days of Receivables |
28.80 | 28.39 | 27.69 | 28.57 | |
Free Cash Flow per Share |
(10.93) | (12.05) | 4.93 | 5.30 | |
Free Cash Flow |
(574.00) | (636.00) | 251.00 | 271.00 | |
Capital Expenditures |
(113.00) | (101.00) | (106.00) | (94.00) | |
| Other line items | |||||
Cash ROIC |
(3.48%) | (3.91%) | 1.45% | 1.59% | |
Accounts Receivable Turnover |
13.15 | 13.30 | 13.04 | 12.11 | |
Accounts Payable Turnover |
32.80 | 32.58 | 34.46 | 34.54 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
10.70 | 10.10 | 10.79 | 10.69 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.23) | (0.20) | (0.18) | 0.17 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.46% | 6.62% | 6.69% | 6.80% | |
Share Based Compensation of Revenue |
0.10% | 0.10% | 0.12% | 0.17% | |
Interest Coverage |
7.60 | 4.07 | 2.12 | 0.97 | |
Operating CF/Net income |
(0.52) | (1.13) | 1.90 | (52.14) | |
Depreciation/Fixed assets |
0.62 | 0.65 | 0.62 | 0.54 | |
Capex/Depreciation |
(0.57) | (0.52) | (0.57) | (0.56) | |
Revenue per Share |
848.57 | 860.34 | 885.56 | 871.27 | |
Operating CF per Share |
(8.78) | (10.13) | 7.01 | 7.14 | |
Capex per Share |
(2.15) | (1.91) | (2.08) | (1.84) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates